Fisher & Paykel Healthcare (NZSE:FPH) Total Liabilities : NZ$638 Mil (As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Total Liabilities?

Fisher & Paykel Healthcare's Total Liabilities for the quarter that ended in Sep. 2023 was NZ$638 Mil.

Fisher & Paykel Healthcare's quarterly Total Liabilities declined from Sep. 2022 (NZ$616.10 Mil) to Mar. 2023 (NZ$451.10 Mil) but then increased from Mar. 2023 (NZ$451.10 Mil) to Sep. 2023 (NZ$638.00 Mil).

Fisher & Paykel Healthcare's annual Total Liabilities declined from Mar. 2021 (NZ$554.10 Mil) to Mar. 2022 (NZ$427.30 Mil) but then increased from Mar. 2022 (NZ$427.30 Mil) to Mar. 2023 (NZ$451.10 Mil).

Fisher & Paykel Healthcare Total Liabilities Historical Data

The historical data trend for Fisher & Paykel Healthcare's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Total Liabilities Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

293.50

461.20

554.10

427.30

451.10

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Liabilities	Get a 7-Day Free Trial															454.60	427.30	616.10	451.10	638.00

Fisher & Paykel Healthcare Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Fisher & Paykel Healthcare's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	289.8	+	(124.5	+	33.7
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	3.1	+	0)
	=	451

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	2204.5	-	1753.4
	=	451

Fisher & Paykel Healthcare's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	286.8	+	(299.6	+	47.8
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	3.8	+	0)
	=	638

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	2389.8	-	1751.8
	=	638

Fisher & Paykel Healthcare Total Liabilities Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.